Ardent Health Inc

ARDT remains in an early Stage 1 consolidation after a terminal decline, trading in a tight range beneath the declining 200 DMA and flat short EMAs. A recent Bullish Exhaustion pattern at the upper boundary signals waning upside momentum and failed breakout attempts. Medium-term bias is bearish, permitting only downside engagement, while short-term timing is neutral. Execution should be deferred, looking to trim into rallies toward resistance near the range highs and 200 DMA.

• ↑Q1’26 revenue rose 7% YoY to $1.6B; adjusted EBITDA jumped 26% to $124M
• ↑Opened four urgent care centers, scaling outpatient services amid rising demand
• ↓Weak profitability and dividend yield factors signal inconsistent returns